Found: 220
Select item for more details and to access through your institution.
670 - Tapinarof cream 1% once daily is efficacious for the treatment of atopic dermatitis in patients with skin of color down to 2 years of age in two pivotal phase 3 trials.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.044
- By:
- Publication type:
- Article
652 - Tralokinumab real-world use in adults with atopic dermatitis: baseline characteristics of the first 100 patients recruited to the TRACE study in the United States.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.031
- By:
- Publication type:
- Article
683 - Risk of major adverse cardiovascular events in patients with moderate-to-severe atopic dermatitis: a United States population-based study.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.057
- By:
- Publication type:
- Article
703 - Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with moderate and/or more extensive atopic dermatitis: subgroup analysis from the TRuE-AD3 study.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.077
- By:
- Publication type:
- Article
699 - Prevalence and incidence of atopic dermatitis in patients with alopecia areata in the United States: a population-based study.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.073
- By:
- Publication type:
- Article
667 - Maintenance of efficacy and safety with nemolizumab at week 48: results from two global phase 3 pivotal studies (ARCADIA-1 and ARCADIA-2) in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.041
- By:
- Publication type:
- Article
732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.105
- By:
- Publication type:
- Article
671 - Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.045
- By:
- Publication type:
- Article
680 - Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.054
- By:
- Publication type:
- Article
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2235, doi. 10.1007/s13555-024-01224-x
- By:
- Publication type:
- Article
Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO‐1 and PSO‐2).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 8, p. 1543, doi. 10.1111/jdv.19925
- By:
- Publication type:
- Article
Depression screening for psoriasis in the United States: A population‐based study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 8, p. e698, doi. 10.1111/jdv.19849
- By:
- Publication type:
- Article
Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1849, doi. 10.1007/s13555-024-01183-3
- By:
- Publication type:
- Article
Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1891, doi. 10.1007/s13555-024-01201-4
- By:
- Publication type:
- Article
Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 6, p. 1615, doi. 10.1007/s13555-024-01188-y
- By:
- Publication type:
- Article
Shared decision-making in psoriasis care: Evaluation of how patients' perception of clinicians' delivery of care changes by age and sex.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0303058
- By:
- Publication type:
- Article
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis.
- Published in:
- Allergy, 2024, v. 79, n. 5, p. 1258, doi. 10.1111/all.15969
- By:
- Publication type:
- Article
Brodalumab: 5-Year US Pharmacovigilance Report.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1349, doi. 10.1007/s13555-024-01162-8
- By:
- Publication type:
- Article
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 5, p. 550, doi. 10.1001/jamadermatol.2023.5439
- By:
- Publication type:
- Article
An OX-Tra'Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 7, p. 587, doi. 10.3390/cells13070587
- By:
- Publication type:
- Article
Comparative efficacy of targeted systemic therapies with topical corticosteroids for moderate-to-severe atopic dermatitis: an updated network meta-analysis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii19, doi. 10.1093/bjd/ljad498.023
- By:
- Publication type:
- Article
Efficacy of upadacitinib and dupilumab on achieving stringent and composite skin and itch outcomes: an indirect comparison of adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii26, doi. 10.1093/bjd/ljad498.029
- By:
- Publication type:
- Article
A global, observational, cohort study of patients with atopic dermatitis to evaluate tralokinumab real-world clinical use (TRACE): baseline characteristics from the first 100 patients in Germany.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii53, doi. 10.1093/bjd/ljad498.055
- By:
- Publication type:
- Article
Tralokinumab real-world use in adults with atopic dermatitis: baseline characteristics of the first 100 patients recruited to the TRACE study in the United States.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii54, doi. 10.1093/bjd/ljad498.056
- By:
- Publication type:
- Article
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 2, p. 421, doi. 10.1007/s13555-023-01089-6
- By:
- Publication type:
- Article
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 204, doi. 10.1001/jamadermatol.2023.5058
- By:
- Publication type:
- Article
Janus-kinase inhibitors in dermatology: A review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2024, v. 90, n. 1, p. 1, doi. 10.25259/IJDVL_15_2023
- By:
- Publication type:
- Article
Evaluation of DermSat-7 for Assessing Treatment Satisfaction in Patients with Acne.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 1, p. 88, doi. 10.1001/jamadermatol.2023.4481
- By:
- Publication type:
- Article
Comorbidity Burden in Psoriasis Patients With Skin of Color.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2024, v. 9, n. 1, p. 16, doi. 10.1177/24755303231198482
- By:
- Publication type:
- Article
Assessing the Quality, Comprehensiveness, and Readability of Online Patient Health Resources About Psoriasis in Skin of Color.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, n. 12, p. 52
- By:
- Publication type:
- Article
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting.
- Published in:
- Journal of Rheumatology, 2023, v. 50, p. 1, doi. 10.3899/jrheum.2023-0496
- By:
- Publication type:
- Article
Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics ?
- Published in:
- Journal of Rheumatology, 2023, v. 50, p. 11, doi. 10.3899/jrheum.2023-0511
- By:
- Publication type:
- Article
GRAPPA 2021 Pilot Grant Award Reports.
- Published in:
- Journal of Rheumatology, 2023, v. 50, p. 36, doi. 10.3899/jrheum.2023-0524
- By:
- Publication type:
- Article
GRAPPA 2022 Trainee Symposium: A Summary of Oral and Poster Presentations.
- Published in:
- Journal of Rheumatology, 2023, v. 50, p. 41, doi. 10.3899/jrheum.2023-0526
- By:
- Publication type:
- Article
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting.
- Published in:
- Journal of Rheumatology, 2023, v. 50, p. 47, doi. 10.3899/jrheum.2023-0528
- By:
- Publication type:
- Article
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 6, p. 939, doi. 10.1007/s40257-023-00806-3
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2589, doi. 10.1007/s13555-023-00977-1
- By:
- Publication type:
- Article
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2839, doi. 10.1007/s13555-023-01034-7
- By:
- Publication type:
- Article
The impact of race on mental health outcomes among patients with hidradenitis suppurativa: A population‐based study in the United States.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 11, p. e1280, doi. 10.1111/jdv.19268
- By:
- Publication type:
- Article
Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 10, p. 2247, doi. 10.1007/s13555-023-01000-3
- By:
- Publication type:
- Article
Readability, quality, and comprehensiveness of online health resources for skin cancer in skin of color.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 10, p. e532, doi. 10.1111/ijd.16674
- By:
- Publication type:
- Article
Deucravacitinib: A Novel TYK2 Inhibitor for the Treatment of Moderate-to-Severe Psoriasis.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2023, v. 8, n. 4, p. 156, doi. 10.1177/24755303231201336
- By:
- Publication type:
- Article
Shared decision-making and satisfaction with care: a population-based study in patients with acne with skin of colour in the USA.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 9, p. 1032, doi. 10.1093/ced/llad151
- By:
- Publication type:
- Article
The effect of perceived health status on satisfaction with care among acne patients: a population-based study.
- Published in:
- Dermatology Online Journal, 2023, v. 29, n. 5, p. 1, doi. 10.5070/D329562419
- By:
- Publication type:
- Article
Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 8, p. 1629, doi. 10.1007/s13555-023-00955-7
- By:
- Publication type:
- Article
Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey.
- Published in:
- Dermatology (10188665), 2023, v. 239, n. 4, p. 621, doi. 10.1159/000528945
- By:
- Publication type:
- Article
Perceptions of biologic treatment among hidradenitis suppurativa patients on social media: an analysis of content, engagement, and sentiment.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 7, p. e379, doi. 10.1111/ijd.16448
- By:
- Publication type:
- Article
395 Assessing imputation methods with the lebrikizumab clinical trial program.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.020
- By:
- Publication type:
- Article